Erin Sparrow

886 total citations
24 papers, 468 citations indexed

About

Erin Sparrow is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Erin Sparrow has authored 24 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 8 papers in Infectious Diseases and 6 papers in Health. Recurrent topics in Erin Sparrow's work include Influenza Virus Research Studies (14 papers), Respiratory viral infections research (11 papers) and Vaccine Coverage and Hesitancy (6 papers). Erin Sparrow is often cited by papers focused on Influenza Virus Research Studies (14 papers), Respiratory viral infections research (11 papers) and Vaccine Coverage and Hesitancy (6 papers). Erin Sparrow collaborates with scholars based in Switzerland, United States and Russia. Erin Sparrow's co-authors include Anthony T. Newall, Siranda Torvaldsen, Guido Torelli, Mohamud Sheikh, James Wood, Daniel R. Feikin, Martin Friede, Kenneth A McLean, Ann Moen and Ruth A. Karron and has published in prestigious journals such as The Lancet, PLoS ONE and The Lancet Infectious Diseases.

In The Last Decade

Erin Sparrow

23 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erin Sparrow Switzerland	13	327	174	82	63	48	24	468
Ashwani Kumar Arora Italy	14	403 1.2×	126 0.7×	66 0.8×	129 2.0×	64 1.3×	39	553
Gabriel Defang United States	12	192 0.6×	127 0.7×	96 1.2×	66 1.0×	12 0.3×	19	403
Alexandre Gaymard France	13	273 0.8×	492 2.8×	163 2.0×	40 0.6×	59 1.2×	30	738
Clinton R. Paden United States	14	247 0.8×	376 2.2×	68 0.8×	49 0.8×	29 0.6×	23	646
Pascale Van Belle Belgium	7	274 0.8×	109 0.6×	108 1.3×	190 3.0×	17 0.4×	7	463
Tyler Bristol United States	9	597 1.8×	262 1.5×	99 1.2×	169 2.7×	51 1.1×	12	785
Claudia P. Arevalo United States	9	202 0.6×	187 1.1×	134 1.6×	176 2.8×	10 0.2×	10	565
Stephan Bart United States	11	303 0.9×	222 1.3×	53 0.6×	69 1.1×	46 1.0×	19	438
Elizabeth M. Coyle United States	17	433 1.3×	462 2.7×	140 1.7×	204 3.2×	47 1.0×	21	815
Marie-Josée Wendling France	10	249 0.8×	336 1.9×	58 0.7×	55 0.9×	10 0.2×	22	639

Countries citing papers authored by Erin Sparrow

Since Specialization

Citations

This map shows the geographic impact of Erin Sparrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Sparrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Sparrow more than expected).

Fields of papers citing papers by Erin Sparrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Sparrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Sparrow. The network helps show where Erin Sparrow may publish in the future.

Co-authorship network of co-authors of Erin Sparrow

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Sparrow. A scholar is included among the top collaborators of Erin Sparrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Sparrow. Erin Sparrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vilajeliu, Alba, Francisco Nogareda, Donald Brooks, et al.. (2025). Global Status of Adult Immunization Post COVID-19 Pandemic. Vaccines. 13(4). 401–401. 1 indexed citations

Taaffe, Jessica, et al.. (2025). Global production capacity of seasonal and pandemic influenza vaccines in 2023. Vaccine. 51. 126839–126839. 5 indexed citations

Hasso-Agopsowicz, Mateusz, Ruth A. Karron, R. Prabhakar Rao, et al.. (2024). Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030. EBioMedicine. 110. 105424–105424. 13 indexed citations

Pecenka, Clint, Erin Sparrow, Daniel R. Feikin, et al.. (2024). Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children. The Lancet. 404(10458). 1157–1170. 20 indexed citations

Hasso-Agopsowicz, Mateusz, Erin Sparrow, Hatim Sati, et al.. (2024). The role of vaccines in reducing antimicrobial resistance: A review of potential impact of vaccines on AMR and insights across 16 vaccines and pathogens. Vaccine. 42(19). S1–S8. 19 indexed citations

Feikin, Daniel R., Ruth A. Karron, Samir K. Saha, et al.. (2023). The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness. The Lancet Infectious Diseases. 24(5). e318–e327. 21 indexed citations

Fitzpatrick, Meagan C., Ranju Baral, Amanda J. Driscoll, et al.. (2023). Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022. Vaccine. 41(48). 7047–7059. 11 indexed citations

Atwell, Jessica E., Chelsea S. Lutz, Erin Sparrow, & Daniel R. Feikin. (2022). Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries. Vaccine. 40(32). 4361–4370. 24 indexed citations

Friede, Martin, et al.. (2022). Technology transfer programme for influenza vaccines – Lessons from the past to inform the future. Vaccine. 40(33). 4673–4675. 6 indexed citations

10.

Sparrow, Erin, Ifedayo Adetifa, Nathorn Chaiyakunapruk, et al.. (2022). WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use. Vaccine. 40(26). 3506–3510. 26 indexed citations

11.

Sparrow, Erin, Mateusz Hasso-Agopsowicz, David C. Kaslow, et al.. (2022). Leveraging mRNA Platform Technology to Accelerate Development of Vaccines for Some Emerging and Neglected Tropical Diseases Through Local Vaccine Production. Frontiers in Tropical Diseases. 3. 6 indexed citations

12.

Kiseleva, Irina, Irina Isakova–Sivak, Marina Stukova, et al.. (2020). A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults. Vaccines. 8(2). 296–296. 6 indexed citations

13.

Sparrow, Erin, James Wood, Anthony T. Newall, et al.. (2020). Global production capacity of seasonal and pandemic influenza vaccines in 2019. Vaccine. 39(3). 512–520. 64 indexed citations

14.

Sparrow, Erin, Siranda Torvaldsen, Anthony T. Newall, et al.. (2018). Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: A review of the current status of the clinical development pipeline. Vaccine. 37. A132–A139. 46 indexed citations

15.

Rudenko, Larisa, Irina Kiseleva, Andrey Rekstin, et al.. (2018). Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model. PLoS ONE. 13(12). e0208028–e0208028. 16 indexed citations

16.

Pitisuttithum, Punnee, Kobporn Boonnak, Supat Chamnanchanunt, et al.. (2017). Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial. The Lancet Infectious Diseases. 17(8). 833–842. 25 indexed citations

17.

Torelli, Guido, et al.. (2016). Stakeholders’ perceptions of 10 years of the Global Action Plan for Influenza Vaccines (GAP) – Results from a survey. Vaccine. 34(45). 5393–5399. 3 indexed citations

18.

McLean, Kenneth A, et al.. (2016). The 2015 global production capacity of seasonal and pandemic influenza vaccine. Vaccine. 34(45). 5410–5413. 59 indexed citations

19.

Sparrow, Erin, Martin Friede, Mohamud Sheikh, Siranda Torvaldsen, & Anthony T. Newall. (2016). Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications. Vaccine. 34(45). 5442–5448. 46 indexed citations

20.

Rudenko, Larisa, Irina Isakova–Sivak, Irina Kiseleva, et al.. (2015). H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Infectious Diseases. 16(3). 303–310. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact